Showing results (121-130 of 224) with videos related to
Sort By:
Pageof 23
Journal of Cancer Research and Clinical Oncology|October 3, 2008
Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapyShin Nishio, Noriyuki Katsumata, Koji Matsumoto, et al.Japanese Journal of Clinical Oncology|July 12, 2008
Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancerMakiko Ono, Takashi Watanabe, Chikako Shimizu, et al.Cancer Science|July 6, 2023
Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016-2018Kayo Nakata, Tomohiro Matsuda, Megumi Hori, et al.Current Drug Safety|June 10, 2014
A descriptive analysis of post-chemotherapy development of interstitial lung disease using spontaneous reporting data in JapanAkihiro Hirakawa, Kan Yonemori, Yachiyo Kuwatsuka, et al.Breast (Edinburgh, Scotland)|April 10, 2007
Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapySadako Akashi-Tanaka, Mutsuko Omatsu, Chikako Shimizu, et al.Acta Medica Okayama|June 28, 2013
p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancerTadahiko Shien, Takayuki Kinoshita, Kunihiko Seki, et al.Hormones & Cancer|September 9, 2011
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancerTakashi Shigekawa, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.Breast Cancer (Tokyo, Japan)|December 13, 2018
Invasive breast cancers in adolescent and young adult women show more aggressive immunohistochemical and clinical features than those in women aged 40-44 yearsAi Hironaka-Mitsuhashi, Hitoshi Tsuda, Masayuki Yoshida, et al.Human Pathology|February 15, 2011
Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapyTakahiro Hasebe, Motoki Iwasaki, Sadako Akashi-Tanaka, et al.Breast Cancer Research and Treatment|February 21, 2008
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcomeTadahiko Shien, Chikako Shimizu, Kunihiko Seki, et al.Pageof 23